John E. Levine

Also affiliated with Icahn School of Medicine at Mount Sinai

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile

0.563Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD

Blood Advances(2024)10.1182/bloodadvances.2024012561

Top 35%

0.563DataRank

Top 35%19 citations

Haesook T. Kim, Nikolaos Spyrou, Nikolaos Katsivelos, Steven Kowalyk, Gilbert Eng +22 more

Papers

Driven by 33 papers — median percentile 65. Top paper: “Biomarker-guided preemption of steroid-refractory graft-versus-host disease with α-1-antitrypsin”.

Biomarker-guided preemption of steroid-refractory graft-versus-host disease with α-1-antitrypsin

Blood Advances(2020)10.1182/bloodadvances.2020003336

N/A

1.0DataRank · unranked

38 citations

Zachariah DeFilipp, Umut Özbek, Karamjeet Sandhu, Aaron Etra, Hannah Choe +24 more

Effective treatment of low-risk acute GVHD with itacitinib monotherapy

Blood(2022)10.1182/blood.2022017442

N/A

0.915DataRank · unranked

44 citations

Alexandra Capellini, Amin Alousi, Monzr M. Al Malki, Hannah Choe, Zachariah DeFilipp +25 more

Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease

Blood Advances(2023)10.1182/bloodadvances.2023009853

N/A

0.794DataRank · unranked

25 citations

Kaitlyn London, Janna Baez, Yu Akahoshi, William J. Hogan, Aaron Etra +32 more

The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD

Blood Advances(2024)10.1182/bloodadvances.2024012561

Top 35%

0.563DataRank

Top 35%19 citations

Haesook T. Kim, Nikolaos Spyrou, Nikolaos Katsivelos, Steven Kowalyk, Gilbert Eng +22 more

Hematopoietic cell transplant compared with standard care in adolescents and young adults with sickle cell disease

Blood Advances(2024)10.1182/bloodadvances.2024013926

N/A

0.389DataRank · unranked

11 citations

Mary Eapen, Yiwen Liu, Fuad El Rassi, Edmund K. Waller, John E. Levine +27 more

18F-FLT PET and Blood-based Biomarkers for Identifying Gastrointestinal Graft versus Host Disease after Allogeneic Cell Transplantation

Radiology Imaging Cancer(2024)10.1148/rycan.240096

N/A

0.224DataRank · unranked

2 citations

Lacey R. McNally, John E. Levine, James L.M. Ferrara, Sara K. Vesely, Christopher G. Kanakry +8 more

Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD

Blood Advances(2023)10.1182/bloodadvances.2023009885

N/A

0DataRank · unranked

42 citations

Nikolaos Spyrou, William J. Hogan, Francis Ayuk, Zachariah DeFilipp, Daniela Weber +31 more

The utility of biomarkers in acute GVHD prognostication

Blood Advances(2023)10.1182/bloodadvances.2023009929

N/A

0DataRank · unranked

18 citations

Yu Akahoshi, Francis Ayuk, Ernst Holler, Hannah Choe, Aaron Etra +29 more

Inhibition of RIP1 improves immune reconstitution and reduces GVHD mortality while preserving graft-versus-leukemia effects

Science Translational Medicine(2023)10.1126/scitranslmed.adf8366

N/A

0DataRank · unranked

18 citations

Seihwan Jeong, Alberto Utrero‐Rico, Tatiana Goncharov, Joshua D. Webster, Ernst Holler +7 more

Galectin-3 predicts acute GvHD and overall mortality post reduced intensity allo-HCT: a BMT-CTN biorepository study

Bone Marrow Transplantation(2023)10.1038/s41409-023-02168-0

N/A

0DataRank · unranked

9 citations

Kristopher Attwood, Xiaojun Liu, George L. Chen, Hans Minderman, Amin M. Alousi +16 more

Reg3α concentrations at day of allogeneic stem cell transplantation predict outcome and correlate with early antibiotic use

Blood Advances(2023)10.1182/bloodadvances.2022008480

N/A

0DataRank · unranked

10 citations

Markus Weber, Elisabeth Meedt, Sakhila Ghimire, Daniel Wolff, Matthias Edinger +19 more

Children's Oncology Group's 2023 blueprint for research: Cellular therapy and stem cell transplantation

Pediatric Blood & Cancer(2023)10.1002/pbc.30577

N/A

0DataRank · unranked

4 citations

Catherine M. Bollard, Mitchell S. Cairo, Joseph H. Chewning, Terry J. Fry, Michael A. Pulsipher +4 more

Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002

Bone Marrow Transplantation(2023)10.1038/s41409-023-02110-4

N/A

0DataRank · unranked

3 citations

Mehdi Hamadani, Michael J. Martens, Haris Ali, Patrice Chevallier, Hannah Choe +20 more

Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis

Blood Advances(2024)10.1182/bloodadvances.2023012091

N/A

0DataRank · unranked

18 citations

Nikolaos Spyrou, Matthias Hoepting, Paibel Aguayo‐Hiraldo, Francis Ayuk, Chantiya Chanswangphuwana +31 more

Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHD

Blood Advances(2024)10.1182/bloodadvances.2023011049

N/A

0DataRank · unranked

14 citations

Najla El Jurdi, Nikolaos Katsivelos, Deukwoo Kwon, Stephanie Gergoudis, George Morales +33 more

A Day 14 Endpoint for Acute GVHD Clinical Trials

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.01.079

N/A

0DataRank · unranked

11 citations

Yu Akahoshi, Steven Kowalyk, George Morales, Rahnuma Beheshti, Paibel Aguayo‐Hiraldo +36 more

Long‐term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trial

American Journal of Hematology(2024)10.1002/ajh.27251

N/A

0DataRank · unranked

7 citations

Jianqun Kou, Martin Andreánsky, Monica Bhatia, Joel A. Brochstein, Sonali Chaudhury +15 more

Vascular biomarkers reveal a unique toxicity profile of posttransplant cyclophosphamide: secondary analysis of BMT CTN 0402 and 1202

Blood Vessels Thrombosis & Hemostasis(2024)10.1016/j.bvth.2024.100020

N/A

0DataRank · unranked

4 citations

Najla El Jurdi, B Betts, Corey Cutler, Joseph H. Antin, John E. Levine +3 more

Differences in Acute Graft-Versus-Host Disease (GVHD) Severity and Its Outcomes Between Black and White Patients

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.08.019

N/A

0DataRank · unranked

2 citations

Muna Qayed, Aaron Etra, Ran Reshef, Richard Newcomb, Nicholas Yuhasz +29 more

Serial Clinical and Biomarker Monitoring during Graft-Versus-Host Disease Treatment Identifies Distinct Risk Strata Including an Ultra-Low Risk Group

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.10.012

N/A

0DataRank · unranked

1 citations

Nikolaos Spyrou, Daniela Weber, Ingrid Vášová, Francis Ayuk, Hannah Choe +28 more

Hematopoietic Cell Transplant compared with Standard Care in Adolescents and Young Adults with Sickle Cell Disease.

UNC Libraries(2024)10.17615/hp8s-ze55

N/A

0DataRank · unranked

0 citations

Edmund K. Waller, Jennifer Jaroscak, Adam Mendizabal, Kimberly A. Kasow, Vamsi Kota +27 more

The MAGIC composite response: a novel end point integrating clinical and biomarker parameters for acute GVHD

Blood Advances(2025)10.1182/bloodadvances.2025017116

N/A

0DataRank · unranked

7 citations

Joseph Portelli, Nikolaos Katsivelos, Ioannis Louloudis, Paibel Aguayo‐Hiraldo, Francis Ayuk +32 more

Harmonized immune recovery monitoring after HCT: evidence and practical guidance from the Westhafen Intercontinental Group

Blood Advances(2025)10.1182/bloodadvances.2025016915

N/A

0DataRank · unranked

7 citations

Silvia Nucera, A. Lucas, Marc Ansari, Adriana Balduzzi, Alice Bertaina +22 more

Donor telomeres and their magnitude of shortening post-allogeneic haematopoietic cell transplant impact survival for patients with early-stage leukaemia or myelodysplastic syndrome

EBioMedicine(2025)10.1016/j.ebiom.2025.105641

N/A

0DataRank · unranked

6 citations

Hormuzd A. Katki, Tsung‐Po Lai, Paul L. Auer, Casey Dagnall, Caitrin Bupp +11 more

A Randomized Clinical Trial Evaluating Lactiplantibacillus Plantarum for the Prevention of GI aGvHD: A Report From the Children’s Oncology Group (ACCL1633)

Transplantation and Cellular Therapy(2025)10.1016/j.jtct.2025.04.009

N/A

0DataRank · unranked

3 citations

William Collier, Hyung Seok Park, Jeffery J. Auletta, Christopher C. Dvorak, Avery August +11 more

Understanding Telomere Biology in Hematopoietic Cell Transplantation: A Dynamical Systems Perspective

medRxiv(2025)10.1101/2025.01.20.24319630

N/A

0DataRank · unranked

0 citations

Morgan Horton, Haniya Khalid, Elizabeth Krieger, Tsung‐Po Lai, Stephen R. Spellman +6 more

Obesity induces gut microbiota alterations and augments acute graft-versus-host disease after allogeneic stem cell transplantation

Science Translational Medicine(2020)10.1126/scitranslmed.aay7713

N/A

0DataRank · unranked

50 citations

Catherine T. Le, Chien-Chun Steven Pai, Robin Shields‐Cutler, Shernan G. Holtan, Armin Rashidi +22 more

Understanding Telomere Biology in Hematopoietic Cell Transplantation: A Dynamical Systems Perspective

Transplantation and Cellular Therapy(2025)10.1016/j.jtct.2025.06.024

N/A

0DataRank · unranked

0 citations

Morgan Horton, Haniya Khalid, Elizabeth Krieger, Tsung‐Po Lai, Stephen R. Spellman +5 more

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIb. The 2020 Preemptive Therapy Working Group Report

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.03.029

N/A

0DataRank · unranked

42 citations

Carrie L. Kitko, Stephanie J. Lee, Paul A. Carpenter, Geoff D.E. Cuvelier, Shernan G. Holtan +25 more

Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2021: Looking Forward as the Network Celebrates its 20th Year

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.08.016

N/A

0DataRank · unranked

18 citations

Edward A. Stadtmauer, John E. Levine, Karen K. Ballen, Yi‐Bin Chen, Amy E. DeZern +20 more

Pulmonary, Gonadal, and Central Nervous System Status after Bone Marrow Transplantation for Sickle Cell Disease

UNC Libraries(2021)10.17615/pj8b-5j59

N/A

0DataRank · unranked

0 citations

Thomas V. Adamkiewicz, Jean E. Sanders, Roger Giller, Naynesh Kamani, John E. Levine +19 more

Acute GVHD: New approaches to clinical trial monitoring

Best Practice & Research Clinical Haematology(2022)10.1016/j.beha.2022.101400

N/A

0DataRank · unranked

11 citations

John E. Levine, James L.M. Ferrara, Nikolaos Spyrou

Prognostic Biomarkers for Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Myeloablative Allogeneic Hematopoietic Cell Transplantation: Results from the Blood and Marrow Transplant Clinical Trials Network 1202 Study

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.11.024

N/A

0DataRank · unranked

9 citations

Bradford A. Young, John E. Levine, Ran Reshef, Ryotaro Nakamura, Christopher Strouse +8 more

John E. Levine

Indexed papers

Top data-sharing exemplar

Papers